TrialSpark Stock

trialspark.comHealthcareFounded: 2013Funding to Date: $246.91MM

TrialSpark is a technology company focused on accelerating the pace of clinical trials to bridge the gap between medical research and patients who need treatment.

Register for Details

For more details on financing and valuation for TrialSpark, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for TrialSpark.

Register Today

Team

Management Team

Kit Dobyns
Co-Founder
Benjamine Liu Ph.D
Co-Founder & Chief Executive Officer
Linhao Zhang
Co-Founder

Other companies like TrialSpark in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$327.39MM
Sector
 
 
Sector
Last Round Est. Valuation
$500MM

News

NEW YORK, Sept. 26, 2019 /PRNewswire/ -- 23andMe, the leading consumer genetics company, and TrialSpark, a technology company enabling physician practices to...
The partners announced that they are putting out a request for clinical trial proposals in the areas of dermatology, gastroenterology, pulmonology, endocrinology, ophthalmology, inflammatory diseases, neurology, women’s health and rare diseases.